Polycomb Repression under the Skin  by Pirrotta, Vincenzo
test (depression-like behavior). Impor-
tantly, both cellular and behavioral phe-
notypes could be normalized by treating 
the mice with a GSK3β inhibitor. These 
findings support an emerging view that 
dysfunction of adult hippocampal neuro-
genesis may contribute to manifestations 
of psychiatric disease during adulthood 
(Duan et al., 2007). An intriguing hypoth-
esis is that defects in embryonic neu-
ronal development predispose individu-
als to neuropsychiatric illness, whereas 
dysfunctional neurogenesis in the adult 
(which is dynamically regulated by the 
existing neuronal circuitry) pushes the 
individual over the threshold, resulting in 
the full manifestation of neuropsychiat-
ric disease. Future genetic studies using 
conditional knockout mice to manipulate 
specific cell types in the adult brain will 
help to clarify this model. With many 
exciting new studies underway, the next 
chapter in the saga of DISC1 and its role 
in neural development should soon be 
here.
RefeRences
Beaulieu, J.M., Gainetdinov, R.R., and Caron, 
M.G. (2008). Annu. Rev. Pharmacol. Toxicol. 49, 
327–347.
Chenn, A., and Walsh, C.A. (2002). Science 297, 
365–369.
Chubb, J.E., Bradshaw, N.J., Soares, D.C., Porte-
ous, D.J., and Millar, J.K. (2008). Mol. Psychiatry 
13, 36–64.
Duan, X., Chang, J.H., Ge, S., Faulkner, R.L., Kim, 
J.Y., Kitabatake, Y., Liu, X.B., Yang, C.H., Jordan, 
J.D., Ma, D.K., et al. (2007). Cell 130, 1146–1158.
Faulkner, R.L., Jang, M.H., Liu, X.B., Duan, X., Sail-
or, K.A., Kim, J.Y., Ge, S., Jones, E.G., Ming, G.L., 
Song, H., and Cheng, H.J. (2008). Proc. Natl. Acad. 
Sci. USA 105, 14157–14162.
Kamiya, A., Kubo, K., Tomoda, T., Takaki, M., 
Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, 
C., Okawa, M., et al. (2005). Nat. Cell Biol. 7, 
1167–1178.
Mao, Y., Ge, X., Frank, G.L., Madsion, J.M., Koehl-
ner, A.N., Doud, M.K., Tassa, C., Berry, E.M., Soda, 
T., Singh, K.K., et al. (2009). Cell, this issue.
Marenco, S., and Weinberger, D.R. (2000). Dev. 
Psychopathol. 12, 501–527.
Ross, C.A., Margolis, R.L., Reading, S.A., Pletnikov, 
M., and Coyle, J.T. (2006). Neuron 52, 139–153.
Zhao, C., Deng, W., and Gage, F.H. (2008). Cell 132, 
645–660.Polycomb Repression under the skin
Vincenzo Pirrotta1,*
1Department of Molecular Biology & Biochemistry, Rutgers University, Piscataway, NJ 08854, USA
*Correspondence: pirrotta@dls.rutgers.edu
DOI 10.1016/j.cell.2009.03.004
Polycomb group proteins control a hierarchy of gene expression during the differentiation of stem 
cells. In this issue, Ezhkova et al. (2009) show that repression mediated by Polycomb proteins 
controls the timing of differentiation of precursor cells of the epidermal lineage.Pluripotent cells in the early embryo 
have the capacity to differentiate into 
any cell type to produce all the tissues 
of the adult body but are prevented 
from doing so until the appropriate time 
and place. Initially, the suppression of 
all the various potential pathways of dif-
ferentiation is transient, but once a sin-
gle pathway of differentiation has been 
selected, this suppression is made per-
manent. In embryonic stem (ES) cells 
nearly all genes involved in differentia-
tion are bound by Polycomb-repressive 
complexes 1 and 2 (PRC1 and PRC2) 
and are marked by histone H3 lysine 
27 trimethylation (H3K27me3) (Boyer et 
al., 2006). This discovery suggests that 
mechanisms involving Polycomb group 
(PcG) proteins prevent indiscriminate 
differentiation of ES cells (Figure 1). But 
experiments in which PcG gene func-992 Cell 136, March 20, 2009 ©2009 Elsevietion is knocked down show that the pic-
ture is more complicated at later stages 
of cell commitment. In this issue of Cell, 
Ezhkova et al. (2009) show that the loss 
of PcG function in epidermal precursor 
cells specifically derepresses genes 
relevant to epidermal differentiation, 
thereby accelerating the rate of normal 
maturation.
In ES cells, genes involved in differen-
tiation that are bound by PcG complexes 
not only bear the repressive H3K27me3 
mark but also are trimethylated at lysine 
4 of histone H3 (H3K4me3), a mark 
associated with transcriptional activ-
ity. The simultaneous presence of both 
repressive and active chromatin marks, 
called the bivalent state (Bernstein et al., 
2006), is in fact accompanied by at least 
some transcriptional activity, suggest-
ing that it signifies an uneasy equilibrium r Inc.between opposing forces. Indeed, mul-
tiple reports have shown that when PcG 
function is knocked down in ES cells, 
the expression of genes controlling 
many differentiation pathways is par-
tially derepressed. Embryos deficient 
in Ezh2, the histone methyltransferase 
component of PRC2, fail to progress 
beyond implantation and do not allow 
the establishment of ES cells (O’Carroll 
et al., 2001).
Is PcG repression then essential to 
maintain the pluripotent state? Surpris-
ingly, it is possible to generate rela-
tively stable ES cells lacking Suz12 or 
Eed, which are essential components of 
the PRC2 complex, perhaps suggest-
ing that Ezh2 has additional functions 
beyond the PRC2 complex. Although 
these cells are depleted of H3K27me3 
and express higher levels of differentia-
tion genes, they continue to proliferate 
and can initiate multiple differentiation 
programs (Montgomery et al., 2005; 
Pasini et al., 2007). Although PcG-
based mechanisms are not essential 
for self-renewal, they are necessary for 
proper differentiation. In their absence, 
gastrulation-specific genes are not acti-
vated and, when PcG-deficient ES cells 
are induced to differentiate, pluripo-
tency genes such as Oct4 and Nanog 
are not turned off, leading to a failure to 
activate genes involved in terminal dif-
ferentiation.
Ezhkova et al. (2009) now make impor-
tant progress in clarifying the role of PcG 
repression in epidermal lineage differ-
entiation. Differentiating epidermal cells 
appear in the 14-day-old mouse embryo 
and arise from a layer of precursors, 
called basal cells, which are attached 
to the basement membrane. Basal cells 
continue to divide, producing a series 
of suprabasal layers. As these cell lay-
ers mature, they progressively lose the 
capacity to proliferate and activate a 
program of differentiation genes, culmi-
nating in an outermost layer consisting 
of dead cells. The authors show that, like 
ES cells, basal cells are rich in Ezh2 and 
other PcG proteins, but as they differen-
tiate Ezh2 expression is turned off and 
the cells exit the cell cycle. To circum-
vent the problem of establishing Ezh2 
null ES cells, the authors constructed 
an Ezh2 gene the excision of which is 
activated under control of a basal cell-
specific promoter. Despite the global 
loss of the H3K27me3 mark that follows 
this conditional inactivation in the basal 
cells, “master” genes corresponding to 
other differentiation pathways do not 
become derepressed, although they 
normally bind to PcG proteins. In con-
trast, Ezh2-deficient basal cells prolifer-
ate more slowly and display precocious 
expression of genes associated with ter-
minal epidermal differentiation, acceler-
ating the normal maturation process of 
epidermal development. Thus, loss of 
PcG function in basal cells selectively 
derepresses genes relevant to epider-
mal differentiation. Among these are 
Ink4A and B, which encode inhibitors of 
cyclin-dependent kinases and therefore 
block entry into S phase and arrest cell-
cycle progression. PcG repression in this 
process appears to control the balance between the proliferative layer of precur-
sor cells and the nonproliferating layers 
of differentiating cells.
Ezhkova et al. show that the entire 
program of epidermal differentiation 
is simply unrolled by the gradual turn-
down of PcG proteins and their repres-
sive effects. In this account, there is no 
evidence that Ezh2 plays a direct role 
in gene activation (as hypothesized by 
Pasini et al., 2007). Loss of Ezh2 is fol-
lowed by loss of H3K27me3. The ensu-
ing derepression of Ink4A/B brings 
about cell-cycle arrest. AP1 transcrip-
tion factors, which are the major effec-
tors of the expression of epidermal 
genes associated with terminal differ-
entiation, are already present in basal 
cells but are prevented from binding to 
their target genes. Loss of PcG function 
makes these binding sites available and 
thereby permits the expression of termi-
nal differentiation genes.
A basic difference between this 
account and other models for PcG func-
tion in ES cells lies in the repression of 
the “master” differentiation genes. Ear-
lier work (such as Pasini et al., 2007 
and Stock et al., 2007) has shown that 
loss of PcG function in ES cells causes 
increased expression of differentiation 
genes and a failure to shut off pluripo-
tency genes when the cells are induced 
to differentiate. However, differentiation 
genes are not fully derepressed, which 
in principle would make it impossible 
to maintain PcG-deficient ES cells. Yet 
such cells have been produced in sev-
eral laboratories. It is possible that ES 
cell lines differ from one another in this 
respect or that the way they are ren-
dered PcG-deficient may cause selec-
tion for alternative pathways of repres-
sion.
More likely, however, differentia-
tion genes in ES cells are controlled 
by an equilibrium of regulatory fac-
tors to which PcG-based mechanisms 
contribute a degree of stabilization. 
That PcG proteins by themselves do 
not completely repress differentiation 
genes is shown by the bivalent chro-
matin state and by the appreciable level 
of transcription that this state sustains. 
There is an increasing appreciation that 
PcG repression of gene expression is 
dynamic and not always incompatible 
with a degree of transcriptional activ-
ity. It is possible in fact that the level 
of transcription in the bivalent state is 
important for preventing DNA methyla-
tion and long-term silencing of differen-
tiation genes, thus helping to maintain 
the pluripotent state.
figure 1. Polycomb Proteins Regulate a Gene Hierarchy in Differentiation
(A) In embryonic stem (ES) cells, mechanisms mediated by Polycomb group (PcG) proteins contribute to 
the stability of the pluripotent state at multiple levels in the gene hierarchy. 
(B) Once cells enter the epidermal pathway, the upper levels of the hierarchy, as well as alternative dif-
ferentiation pathways, are permanently shut off by PcG-independent mechanisms. PcG regulation now 
moves down the gene hierarchy to control the proper deployment of epidermal differentiation genes.Cell 136, March 20, 2009 ©2009 Elsevier Inc. 993
In the work of Ezhkova et al., the con-
ditional knockout of Ezh2 occurs in the 
basal keratinocytes, cells that have already 
entered the epidermal pathway. In these 
cells, the genes controlling the pluripo-
tent state as well as other differentiation 
pathways have been silenced by PcG-
independent processes. Perhaps a model 
for this can be found in the regulation of 
the Oct4 gene: when ES cells are induced 
to differentiate, the Oct4 gene promoter is 
bound by transcriptional repressors, which 
recruit the H3K9 methyltransferase G9a, in 
turn leading to de novo DNA methylation 
and permanent shutdown of its expression 
(Feldman et al., 2006; Epsztejn-Litman et 
al., 2008). In this view, PcG-based mecha-
nisms emerge as the flexible dynamic field 
artillery of genomic repression as opposed 
to the heavy artillery represented by DNA 
methylation.
Is the process of differentiation 
always as simple as the winding down 
of repression and consequent activa-
tion of terminal differentiation genes? 
In vivo there are clearly multiple inputs. 
Lessons from the fruit fly Drosophila 
indicate that correct morphogenesis 
results from new signals derepressing 
key genes modulating epigenetic pat-994 Cell 136, March 20, 2009 ©2009 Elsevie
Many signaling pathways depend criti-
cally on scaffold proteins, which pro-
vide docking sites for various signaling 
components, thus organizing them for 
efficient communication. In insulin sig-
naling, for example, the insulin recep-
A MAPK scaffo
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The scaffold proteins of signaling
together catalytic components o
budding yeast the scaffold prote
protein kinase Fus3, rendering it terns of expression and repression that 
are pre-established at earlier develop-
mental stages and maintained by PcG-
based mechanisms. This is the case for 
the Hox genes and for key morphogens 
such as Hedgehog or Wingless/Wnt.
How are the genes that initiate epider-
mal commitment protected from PcG 
repression so that they can activate the 
pathway? The classical model derived 
from Drosophila suggests that PcG tar-
get genes are also targets for Trithorax 
(TRX) or its mammalian counterpart MLL. 
However, how TRX/MLL antagonizes 
PcG repression is poorly understood.
Little is known about the way PcG 
genes themselves are regulated to permit 
the unfolding of developmental programs. 
In later postnatal development, there 
appears to be little or no Ezh2 detectable 
in basal cells, yet they must continue to 
act as epidermal stem cells to maintain 
the epidermal layers. How do these cells 
continue to divide if Ink4 genes are now 
derepressed in the absence of Ezh2? 
Perhaps, as Ezhkova et al. suggest, Ezh1 
takes over at later stages. Untangling the 
multiple regulatory networks involved in 
differentiation is likely to keep research-
ers busy for years to come.r Inc.
tor substrate 1 (IRS-1) scaffold protein 
provides multiple docking sites for SH2 
proteins that can activate the phos-
phoinositide 3-kinase (p85) and stimu-
late the insulin response (Backer et al., 
1992; Pawson and Scott, 1997). Perhaps 
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